about
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.Prognostic factors of early metastasis and mortality in dogs with appendicular osteosarcoma after receiving surgery: an individual patient data meta-analysis.Bayesian methods including nonrandomized study data increased the efficiency of postlaunch RCTs.Which dogs with appendicular osteosarcoma benefit most from chemotherapy after surgery? Results from an individual patient data meta-analysis.Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.Differences in interaction and subgroup-specific effects were observed between randomized and nonrandomized studies in three empirical examples.Justification of exclusion criteria was underreported in a review of cardiovascular trials.Exploring interaction effects in small samples increases rates of false-positive and false-negative findings: results from a systematic review and simulation study.Association analyses based on false discovery rate implicate new loci for coronary artery disease.Tailoring treatments using treatment effect modification.Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.Comparison of variance estimators for meta-analysis of instrumental variable estimates.Adjusting for Confounding in Early Postlaunch Settings: Going Beyond Logistic Regression Models.Chemotherapy effectiveness and mortality prediction in surgically treated osteosarcoma dogs: A validation study.Linear regression and the normality assumption.Adjusting for bias in unblinded randomized controlled trials.Impact of Selection Bias on Estimation of Subsequent Event Risk.An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors.Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9Comments on 'the use of propensity scores and observational data to estimate randomized controlled trial generalizability bias' by Taylor R. Pressler and Eloise E. Kaizar, Statistics in Medicine 2013Re: Is the Risk Difference Really a More Heterogeneous Measure?Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular diseaseObesity causes cardiovascular diseases: adding to the weight of evidencePhenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9When drug treatments bias genetic studies: Mediation and interaction
P50
Q30234612-10AE1F5C-15DE-4A5F-92CC-2E4B2A45B0FCQ30668686-0FF1F34C-B2D5-48C7-9C2B-7BDE0F9F5D48Q30882532-519F1256-7DE2-4848-902E-E7EA31684472Q31038907-3D019433-2B45-4D70-8AED-2F77B119E5D5Q36206751-43D72D9C-A428-4797-823D-F03A06DB7BC3Q37607330-CB8A510B-FD58-41A9-BF94-C24569A2AC12Q38091155-C51DDE36-119B-4DBF-98B4-6F91FED84DCBQ38194753-97D52ABA-CC2D-4BF4-8076-3CB82946A4DBQ38207306-008823AB-50BD-4297-8159-ECC0A46A0204Q38675868-BEFF71BA-3BFE-4FC5-ACB6-573F719222E0Q38733650-9961F2FC-EF8C-4C15-A54A-17E60A9C5720Q38752767-C643AB59-D15F-4062-B8E8-AC8FA8B8AC40Q39437071-4A2F9218-63C4-405A-9462-C7097796D67DQ40467313-0309C88E-E975-41C4-B307-7C64F05E664EQ40940595-B62FDF05-2345-4610-9412-33F85BDF0E19Q47280939-5812E037-8D55-4261-9965-1FF526BE6DC0Q48652856-6DFD9FE2-B033-4E4B-9A0D-401318B83767Q49547935-2D2FF2CA-78DB-4E08-AA2F-34A993EF3003Q52675579-EC14C94A-45C4-4750-9B75-DE55C6465A17Q62664266-765D9DEA-30E3-47F2-AEB6-47B7EC0D167EQ87043424-2575B0B9-761C-4D48-A7AC-E363E4365BA8Q87154706-5836E54F-84A2-49A5-A521-81034312432AQ87789546-66335318-BE62-4254-82D5-75853450A653Q90027030-B9D165AF-15DA-49F1-9F2C-67760A325DD8Q91004367-88AD9BCB-E336-4B92-926A-7E8FFBA415FBQ92956570-E4DCCD12-7F6C-4CFF-90CC-612FBD4FB586
P50
description
onderzoeker
@nl
researcher
@en
researcher
@en-gb
հետազոտող
@hy
name
Amand F Schmidt
@ast
Amand F Schmidt
@en
Amand F Schmidt
@en-gb
Amand F Schmidt
@es
Amand F Schmidt
@nl
Amand F Schmidt
@sl
type
label
Amand F Schmidt
@ast
Amand F Schmidt
@en
Amand F Schmidt
@en-gb
Amand F Schmidt
@es
Amand F Schmidt
@nl
Amand F Schmidt
@sl
altLabel
Schmidt AF
@en
prefLabel
Amand F Schmidt
@ast
Amand F Schmidt
@en
Amand F Schmidt
@en-gb
Amand F Schmidt
@es
Amand F Schmidt
@nl
Amand F Schmidt
@sl
P1053
G-6602-2017
P106
P1153
55622055900
P31
P496
0000-0003-1327-0424